CTRI/2024/03/064716尚未招募3 期
Romiplostim in pediatric patients post hematopoietic stem cell transplantation for early platelet engraftment: An open label randomised controlled trial - NI
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •undergoing allogenic or autologous hematopoietic stem cell transplantation
排除标准
- •1. History of thrombotic events in the past
- •2. Received thrombopoietic agents in the past
- •3. non consenting guardian
- •4. Second transplant
- •5. Bone marrow not in remission at the transplant
- •6. Reduced-intensity conditioning transplant
- •7. Umbilical cord blood transplant
研究者
相似试验
尚未招募
2 期
se of romiplostim in children with cancers requiring high dose of chemotherapy, to accelerate platelet count recoveryCTRI/2023/02/049906Dr. SHIVAM BANSA
招募中
不适用
ate Effects and Follow up after pediatric hematological stem cell transplantation and cell therapy (LEEF)<p>Inborn errors of immunity, hemoglobinopathies, and bone marrow failure.</p>NL-OMON20380one250
暂停
不适用
Randomized trial on the use of rhEPO in neonates with Rhesus alloimmunization.Recombinant Human Erythropoietin (rhEPO)Hemolytic Disease of the Newborn Red blood cell alloimmunization Intrauterine red cell transfusionNL-OMON26568eiden University Medical Center (LUMC)132
进行中（未招募）
1 期
Romiplostim for thrombocytopenia induced by lomustine at first progression of MGMT promoter-methylated glioblastoma: a randomized phase II open label multicenter studyEUCTR2020-005429-10-ESEuropean Organisation for Research and Treatment of Cancer EORTC100
进行中（未招募）
1 期
Romiplostim for thrombocytopenia induced by lomustine at first progression of MGMT promoter-methylated glioblastoma: a randomized phase II open label multicenter studythrombocytopenia caused by chemotherapy drug lomustineEUCTR2020-005429-10-ITEORTC AISBL/IVZW100